Sectoral Asset Management’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-27,987
Closed -$253K 109
2018
Q4
$253K Hold
27,987
0.03% 80
2018
Q3
$462K Buy
+27,987
New +$496K 0.05% 89
2016
Q1
Sell
-15,940
Closed -$366K 84
2015
Q4
$366K Sell
15,940
-558
-3% -$14.4K 0.02% 75
2015
Q3
$331K Buy
16,498
+524
+3% +$15.9K 0.02% 77
2015
Q2
$462K Buy
15,974
+3,318
+26% +$83.9K 0.02% 74
2015
Q1
$387K Buy
+12,656
New +$327K 0.01% 77

Other funds holding CHRS

Sectoral Asset Management's CHRS Position: Q1 2019 in Review

Sectoral Asset Management sold out of Coherus Oncology (CHRS) in Q1 2019, closing a stake of 27,987 shares — an estimated $253K sold.

Sectoral Asset Management first reported a position in CHRS in Q1 2015 and held it in 6 quarters. The position peaked at $462K in Q3 2018. 117 funds tracked by Wall St. Rank hold CHRS as of Q1 2019.

  • Sectoral Asset Management reported no remaining Coherus Oncology position as of Q1 2019 after selling out during the quarter.
  • Sectoral Asset Management sold 27,987 Coherus Oncology shares in Q1 2019, an estimated $253K.
  • Sectoral Asset Management first reported a position in Coherus Oncology in Q1 2015 and held it in 6 quarters.
  • Sectoral Asset Management's Coherus Oncology position peaked at $462K in Q3 2018.
  • 117 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2019.

Based on Sectoral Asset Management's 13F filing for Q1 2019, filed 14 May 2019.